A Randomised Trial of Six Versus Twelve Courses of Chemotherapy in Metastatic Carcinoma of the Breast

Author： Gregory R.K.   Powles T.J.   Chang J.C.   Ashley S.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.13, 1997-11, pp. : 2194-2197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients

By Chiarion-Sileni V.   Del Bianco P.   De Salvo G.L.   Re G.L.   Romanini A.   Labianca R.   Nortilli R.   Corgna E.   Palma M.D.   Presti G.L.   Ridolfi R.   on behalf of the Italian Melanoma Intergroup IMI  

European Journal of Cancer, Vol. 39, Iss. 11, 2003-07 ,pp. : 1577-1585

Elsevier

Access to resources Recommend Favorite

Randomised Phase II Study of Epirubicin-Vindesine Versus Mitoxantrone-Vindesine in Metastatic Breast Cancer

By Hausmaninger H.   Lehnert M.   Steger G.   Sevelda P.   Tschurtschenthaler G.   Hehenwarter W.   Fridrik M.   Samonigg H.   Schiller L.   Manfreda D.   Haidinger R.   Kienzer R.   Kemmler G.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2169-2173

Elsevier

Access to resources Recommend Favorite

Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin

By Venturino A.  

Breast Cancer Research and Treatment, Vol. 60, Iss. 3, 2000-04 ,pp. : 195-200

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: Pivotal trial data

By Eiermann W.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 57-62

Springer Publishing Company

Access to resources Recommend Favorite

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T.   Carlsson L.   Einbeigi Z.   Lidbrink E.   Linderholm B.   Lindh B.   Loman N.   Malmberg M.   Rotstein S.   Söderberg M.   Sundquist M.   Walz T.   Hellström M.   Svensson H.   Åström G.   Brandberg Y.   Carstensen J.   Fernö M.   Bergh J.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite